Clume Health vs MyDrHank

Strengths

• +One Signature price covers semaglutide or tirzepatide, injectable or oral, so switching molecule or route does not change the bill
• +A separate microdose and maintenance program is priced on its own at $219 a month rather than sold as a discount on the main line
• +Names four dispensing pharmacies with street addresses and phone numbers, which is more than most of the field publishes
• +States service in all 50 states plus Washington, D.C. without contradicting itself elsewhere
• +A full refund is available if the subscription is canceled within the first 72 hours and before the medication ships

Where it loses points

• –Neither homepage hero price matches anything sold: $199 a month is advertised against real floors of $259 and $219, and $159 against a figure of $216 that itself needs a 12-week plan
• –Both hero prices carry an asterisk that resolves to no footnote anywhere on the page
• –The cheaper monthly figures are commitments — $186 needs 52 weeks and $200 needs 12 — printed on the same card as the month-to-month rate
• –The refund policy promises a 24/7 patient support line and no phone number appears anywhere on the site; support is email only
• –Whether the medication is compounded, and under 503A or 503B, is never stated
• –No clinician is named. The Terms name only “the OpenLoop Medical Practices”, with no individual, no NPI and no medical group entity

Strengths

• +Prices are published openly on the product pages, before any intake quiz — most compounded competitors gate the number behind a questionnaire
• +A real oral semaglutide tablet ($249/mo month-to-month) beside the weekly injection, so the needle is optional on the semaglutide line
• +The GLP-1 pages state the price stays the same at every dose, so titrating up does not raise the monthly cost
• +Six prescription lines on one account — weight loss, longevity, peptides and NAD+, sexual health, hair growth and strength — with free shipping included
• +Clean against the FDA warning-letter database: no letter on file under the brand, the entity or the domain

Where it loses points

• –Every price MyDrHank displays is the twelve-month prepay rung — its price component renders the cheapest term in the ladder, so the month-to-month rate ($259 semaglutide, $349 tirzepatide) appears on no page on the site
• –Month-to-month, it is expensive: $259 semaglutide against a $179 median across the providers here that disclose one, and $349 tirzepatide against a $249 median
• –One advertised price is purchasable at no tier — a footnote quotes "$200/mo for compounded tirzepatide" when the cheapest tirzepatide rung is $240, and the "$171/mo" beside it is the oral product's yearly rate, not injectable semaglutide's ($178)
• –An FAQ describes a twelve-month prepay rate as a plan with "no contract"
• –Compounded only and not FDA-approved — no brand Wegovy, Ozempic, Zepbound or Mounjaro lane at any price
• –The operating entity is named — Dr. Hank, LLC, credited in the privacy policy and terms of use — but nobody clinical is: no medical director or prescriber appears anywhere, no lab or monitoring program is published, and the compounding pharmacy is described only as "an FDA-registered U.S. pharmacy"
• –The trust row reads "HIPAA-aware", not HIPAA-compliant — a hedge worth noticing on a site handling prescription intake
• –No served-states list appears on the consumer site; the affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia